EMS is the largest pharmaceutical company in Brazil and one of the major players in the Latin American market. It was founded in 1964 by the businessman and pharmacist, Edson de Godoy Bueno. Initially, EMS focused on providing private label products and services to other pharmaceutical companies.

However, over the years, the company expanded its operations and began manufacturing its own products. The headquarters of EMS is located in Hortolândia, São Paulo, Brazil. With state-of-the-art facilities and a commitment to quality, the company has become a leader in the Brazilian pharmaceutical industry.

EMS has a strong presence in the research and development of innovative medicines and invests heavily in technology and innovation. EMS offers a wide range of products and services, including prescription drugs, over-the-counter medications, generic drugs, vaccines, and personal care products. The company is known for its high-quality and affordable products, serving a diverse range of medical needs.

On a global scale, EMS has established several subsidiaries, joint ventures, and partnerships. It has a presence in Latin American countries such as Argentina, Chile, Mexico, and Colombia. The company also has a subsidiary in the United States, called EMS Pharma, which focuses on the development and commercialization of generic drugs.

In terms of market position, EMS has been consistently ranked as the largest pharmaceutical company in Brazil, with a significant market share. It has also gained recognition globally for its products and has become one of the top pharmaceutical companies in Latin America. EMS faces competition from both local and international pharmaceutical companies.

However, its strong brand reputation, extensive product portfolio, and focus on innovation have contributed to its leading position in the market. EMS has achieved several milestones and made significant contributions to the healthcare industry. It has received numerous awards and certifications for its excellence in manufacturing, research, and development.

The company's growth strategy includes expanding its product portfolio, entering new markets, and investing in cutting-edge technologies. As of the latest updates, EMS continues to thrive in the pharmaceutical industry. It has maintained its market leadership in Brazil and has expanded its presence in international markets.

The company remains committed to innovation and providing high-quality healthcare solutions to patients worldwide